Clinical Trials
51
Active:12
Completed:9
Trial Phases
4 Phases
Phase 1:9
Phase 3:17
Phase 4:17
+1 more phases
Drug Approvals
17
PHILIPPINES:16
NMPA:1
Drug Approvals
Rasagiline Mesylate Tablets
- Product Name
- 甲磺酸雷沙吉兰片
- Approval Number
- 国药准字HJ20240043
- Approval Date
- Jun 18, 2024
NMPA
Clinical Trials
Distribution across different clinical trial phases (49 trials with phase data)• Click on a phase to view related trials
Phase 3
17 (34.7%)Phase 4
17 (34.7%)Phase 1
9 (18.4%)Not Applicable
6 (12.2%)No trials found
News
Indian Pharma Companies to Launch Generic Empagliflozin at 90% Lower Cost
Several Indian pharmaceutical companies are preparing to launch generic versions of Empagliflozin following Boehringer Ingelheim's patent expiry on March 11, potentially transforming diabetes treatment accessibility.
Sonnet BioTherapeutics Advances Pipeline with Clinical Data and Strategic Partnerships
Sonnet BioTherapeutics reported stable disease in 48% of evaluable monotherapy patients in the Phase 1 SB101 trial for SON-1010 (IL12-FHAB).